New bacterial therapy approach to treat lung cancer


NIBIB in the News
December 30, 2022

Columbia biomedical engineers develop therapeutic strategy to combine bacterial therapies with pharmaceutical drugs

Researchers report that they have developed a new experimental pipeline to combine bacterial therapy with current cancer drugs. Their study, which explores resistance to bacterial therapy at the molecular level, has achieved better treatment efficacy without additional toxicity in laboratory models. Source: Columbia University School of Engineering and Applied Science/Science Daily